MAM
Joy Mohanty to head creative for Lowe Lintas, North & East
MUMBAI: Lowe Lintas has appointed Joy Mohanty as regional president – North & East. Mohanty will lead the creative function for the Delhi and Kolkata offices of Lowe Lintas reporting to CCO Arun Iyer.
In a career spanning 23 years, Joy has worked with leading agencies in India. His last assignment was as National Creative Director, Publicis Capital, from where he moves after over 11 years. His portfolio includes work for leading clients like Maruti Suzuki Corporate, Makemytrip, Maggi, Nescafe Sunrise, Nestle Every Day, Milkmaid, Intex, Subway, Spicejet, Swift, Apollo Tyres, Suzuki Motorcycles, LG Home Appliances and others.
Welcoming Mohanty to the agency, Arun Iyer said, “Lowe Lintas Delhi has been buzzing with some spectacular work in the recent past. Having someone like Joy Mohanty lead and drive the creative function, will further consolidate our reputation as being the most creative agency in Delhi, as also to push forward the creative agenda in Kolkata. We welcome him wholeheartedly and look forward to working closely with him to usher in an even stronger creative culture in these 2 offices of Lowe Lintas.”
Prior to Publicis Capital, Joy was with Contract Advertising as Creative Director. Preceding that he worked as Creative Director, Enterprise Nexus and was also at Leo Burnett as Associate Creative Director. He handled brands like LML Motorcycles, Opel Corsa, Chevrolet Optra, 8PM Whisky, Thums Up, Limca, Maaza, Dabur Chyawanprash, Somany Tiles, Dabur Honey, Escotel Mobile, etc.
Speaking about his new role at Lowe Lintas, Mohanty added: “It’s a great feeling to be part of an institution like Lowe Lintas. I have admired their work over the years. It will be an honour for me to add energy and momentum to a body of work already making waves. I can’t wait to get started.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
